Wrapsody

Wrapsody is a cell-impermeable endoprosthesis designed to enhance vascular access, particularly in arteriovenous (AV) fistula patients. It has demonstrated superior patency compared to standard care in clinical trials, such as the Wrapsody WAVE trial. This device is engineered to improve the durability and functionality of vascular access sites, which are crucial for patients undergoing dialysis or other treatments requiring frequent access to the bloodstream.

The Wrapsody endoprosthesis is intended to reduce complications associated with AV fistula failure, such as stenosis or thrombosis, by providing a stable and durable conduit for blood flow. Its design aims to minimize the risk of infection and promote better healing, which can lead to fewer interventions and improved patient outcomes.

Incorporating advanced materials and technology, Wrapsody offers a solution for vascular specialists seeking to enhance the longevity and effectiveness of AV fistulas. Its approval and use reflect ongoing advancements in vascular surgery and the management of chronic conditions requiring vascular access.